<DOC>
	<DOC>NCT01167764</DOC>
	<brief_summary>Hemoptysis is one of the serious complication of many pulmonary diseases. Upto now, there is no proven medical treatment in recurrence of hemoptysis. The investigators will conduct a randomized, placebo controlled trial of tranexamic acid, which can reduce the recurrence of hemoptysis.</brief_summary>
	<brief_title>Effect of Tranexamic Acid on Prevention of Recurrence of Hemoptysis</brief_title>
	<detailed_description />
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Hemoptysis</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>age: &gt;=20 and &lt;=75 ER visit or admission for hemoptysis no evidence of hemoptysis on screening anticoagulation treatment Cr &gt;= 2.0 mg/dL or urinary protein &gt;= 2+ or who received renal replacement treatment hepatic failure: total bilirubin &gt;= 1.5 mg/dL or AST or ALT &gt;= 1.5 of upper normal limit level hypersensitivity to tranexamic acid pregnant woman fertile female who don't use contraception</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>hemoptysis</keyword>
	<keyword>recurrence</keyword>
</DOC>